KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Capital Employed (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 15 years of Return on Capital Employed data on record, last reported at 0.0% in Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 6.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, down 6.0%, while the annual FY2025 figure was 0.04%, 11.0% down from the prior year.
  • Return on Capital Employed reached 0.0% in Q4 2025 per JAZZ's latest filing, down from 0.06% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.12% in Q1 2021 and bottomed at 0.01% in Q4 2022.
  • Average Return on Capital Employed over 5 years is 0.03%, with a median of 0.02% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: increased 8bps in 2021, then decreased -6bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.01% in 2021, then crashed by -146bps to 0.01% in 2022, then skyrocketed by 975bps to 0.06% in 2023, then rose by 9bps to 0.06% in 2024, then plummeted by -97bps to 0.0% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.0% in Q4 2025, 0.06% in Q4 2024, and 0.05% in Q1 2024.